High resolution neural implants for the treatment of epilepsy
An Australian MedTech company developing miniaturised, high resolution seizure prediction technology to improve epilepsy outcomes.
Carbon Cybernetics is an Australian MedTech company developing miniaturised, high resolution seizure prediction technology to improve the lives of those suffering from neurological diseases.
Delivered by MTPConnect, the Australian Government’s $45 million BioMedTech Horizons program, is a Medical Research Future Fund (MRFF) initiative to support innovative collaborative health technologies, drive discoveries towards proof-of-concept and commercialisation that address key health challenges as well as maximise entrepreneurship and idea potential.
Our world-leading team has developed carbon-based implants for carbon-based lifeforms. These devices are suitable for life-long implantation and use brain signals to forecast seizure activity.
Curious to know more?
Get in touch with us today and ask about our new seizure forecasting technology.